PRESENTACION Y EVALUACION DE LA HIPERTENSION EN EL EMBARAZO





PRESENTACION Y EVALUACION DE LA HIPERTENSION EN EL EMBARAZO

(especial para SIIC © Derechos reservados)
La preeclampsia es la hipertensión de novo con proteinuria después de las 20 semanas de gestación. Es el trastorno hipertensivo del embarazo con mayor potencial para producir la muerte.
cetin9.jpg Autor:
Ali Cetin
Columnista Experto de SIIC

Institución:
Cumhuriyet University School of Medicine


Artículos publicados por Ali Cetin
Recepción del artículo
5 de Agosto, 2007
Aprobación
7 de Enero, 2008
Primera edición
15 de Diciembre, 2008
Segunda edición, ampliada y corregida
7 de Junio, 2021

Resumen
La preeclampsia es la hipertensión de novo con proteinuria después de las 20 semanas de gestación. Las pacientes con preeclampsia grave tienen uno o más hallazgos como cefalea grave, dolor en hipocondrio derecho o epigastrio, concentración sérica de transaminasas de al menos el doble de lo normal, presión sistólica > 160 mm Hg o diastólica > 110 mm Hg en dos ocasiones separadas por lo menos por seis horas, menos de 100 000 plaquetas por mm3, proteinuria > 5 g/24 horas, oliguria o restricción grave del crecimiento fetal. Es el trastorno hipertensivo del embarazo con mayor potencial para producir la muerte. En esta revisión se explica la presentación clínica y la evaluación de la preeclampsia con sus formas graves, la eclampsia y el síndrome HELLP.

Palabras clave
preeclampsia, eclampsia, síndrome HELLP, hipertensión


Artículo completo

(castellano)
Extensión:  +/-8.73 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
Preeclampsia is de novo hypertension with proteinuria after 20 weeks of gestation. Patients with severe preeclampsia have one or more of the findings such as severe headache, right upper quadrant or epigastric pain, serum transaminase concentration at least twice normal, systolic blood pressure = 160 mm Hg or diastolic = 110 mm Hg on two occasions at least six hours apart, platelets less than 100 000 per cubic millimeter, proteinuria = 5 g/24 hour, oliguria, or severe fetal growth restriction. It is the most life-threatening hypertensive disorders of pregnancy. In this review, clinical presentation and evaluation of preeclampsia with its severe forms, eclampsia and HELLP syndrome, are discussed.

Key words
preeclampsia, eclampsia, HELLP syndrome, hypertension


Full text
(english)
para suscriptores/ assinantes

Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Obstetricia y Ginecología
Relacionadas: Bioquímica, Cardiología



Comprar este artículo
Extensión: 8.73 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Ali Cetin, Cumhuriyet University School of Medicine Department of Obstetrics and Gynecology, 58140, Sivas, Turquía
Bibliografía del artículo

1. Aagaard-Tillery KM, Belfort MA. Eclampsia: morbidity, mortality, and management. Clin Obstet Gynecol 48:12-23, 2005.
2. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 77:67-75, 2002.
3. Afifi Y, Churchill D. Pharmacological treatment of hypertension in pregnancy. Curr Pharm Des 9:1745-53, 2003.
4. Airoldi J, Weinstein L. Clinical significance of proteinuria in pregnancy. Obstet Gynecol Surv 62:117-24, 2007.
5. Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 31:807-33, 2004.
6. Brown MA, Zammit VC, Lowe SA. Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension. Clin Sci (Lond) 77:599-604, 1989.
7. Cetin A. Eclampsia. In Mohler III ER, Townsend RR. Advanced therapy in hypertension and vascular disease. Ontario, BC Decker Inc., pp. 407-15, 2006.
8. Cetin A. Hemolysis, elevated liver enzymes, and low platelets (HELLP). In Mohler III ER, Townsend RR. Advanced therapy in hypertension and vascular disease. Ontario, BC Decker Inc, pp. 416-20, 2006.
9. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330:565-71, 2005.
10. Duley L, Meher S, Abalos E. Management of pre-eclampsia. BMJ 332:463-8, 2006.
11. Frishman WH, Schlocker SJ, Awad K, Tejani N. Pathophysiology and medical management of systemic hypertension in pregnancy. Cardiol Rev 13:274-84, 2005.
12. Henry CS, Biedermann SA, Campbell MF, Guntupalli JS. Spectrum of hypertensive emergencies in pregnancy. Crit Care Clin 20:697-712, 2004.
13. Lopez MC, Belizan JM, Villar J, Bergel E. The measurement of diastolic blood pressure during pregnancy: which Korotkoff phase should be used? Am J Obstet Gynecol 170:574-8, 1994.
14. Magann EF, Martin JN Jr. Critical care of HELLP syndrome with corticosteroids. Am J Perinatol 17:417-22, 2000.
15. McCrae KR. Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management. Blood Rev 17:7-14, 2003.
16. Naylor DF Jr, Olson MM. Critical care obstetrics and gynecology. Crit Care Clin 19:127-49, 2003.
17. O'Brien JM, Barton JR. Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol 48:460-77, 2005.
18. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183:S1-S22, 2000.
19. Sawle GV, Ramsay MM. The neurology of pregnancy. J Neurol Neurosurg Psychiatry 64:717-25, 1998.
20. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103(5 Pt 1):981-91, 2004.
21. Sibai BM. Imitators of severe preeclampsia. Obstet Gynecol 109:956-66, 2007.
22. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 162:311-6, 1990.
23. Solomon CG, Seely EW. Hypertension in pregnancy. Endocrinol Metab Clin North Am 35:157-71, 2006.
24. Steingrub JS. Pregnancy-associated severe liver dysfunction. Crit Care Clin 20:763-76, 2004.
25. Van Pampus MG, Wolf H, Mayruhu G, Treffers PE, Bleker OP. Long-term follow-up in patients with a history of (H)ELLP syndrome. Hypertens Pregnancy 20:15-23, 2001.
26. Van Runnard Heimel PJ, Franx A, Schobben AF, Huisjes AJ, Derks JB, Bruinse HW. Corticosteroids, pregnancy, and HELLP syndrome: A Review. Obstet Gynecol Surv 60:57-70, 2005.
27. Vidaeff AC, Carroll MA, Ramin SM. Acute hypertensive emergencies in pregnancy. Crit Care Med 33(Suppl):S307-12, 2005.
28. Walker SP, Higgins JR, Brennecke SP. The diastolic debate: is it time to discard Korotkoff phase IV in favour of phase V for blood pressure measurements in pregnancy? Med J Aust 169:203-5, 1998.
29. Waugh JJ, Clark TJ, Divakaran TG, Khan KS, Kilby MD. Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy. Obstet Gynecol 103:769-77, 2004.
30. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142:159-67, 1982.

 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618